Skip to main content

Table 4 Linear regression analyses of statin exposure in simvastatin equivalents, n = 87

From: Association between statin use and physical performance in home-dwelling older patients receiving polypharmacy: cross-sectional study

Dependent variable

Unadjusted models a

Adjusted models b

β

B

95% CI for B

β

B

95% CI for B

Grip strength (kg)

0.05

0.01

−0.02 to 0.03

0.03

0.01

−0.02 to 0.03

SPPB (0-12)

0.26

0.02

0.00 to 0.03

0.19

0.01

0.00 to 0.02

Gait speed (m/s)

0.24

0.001

0.000 to 0.002

0.23

0.001

0.000 to 0.002

  1. β is the standardized regression coefficient. B is the unstandardized regression coefficient and equals the estimated change in the dependent variable per milligram increase in statin exposure expressed as simvastatin equivalents, taking into account statin potency, drug-drug interactions and SLCO1B1 genotype. Estimates in bold letters indicate a p-value below 0.05
  2. aModel for grip strength adjusted for gender
  3. bAll models adjusted for age, gender, body mass index, Cumulative Illness Rating Scale, Functional Independence Measure and Clinical Dementia Rating Scale